Cargando…
α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology
BACKGROUND: Passive and active immunization with α-synuclein has been shown to be neuroprotective in animal models of Parkinson’s disease. We have previously shown that vaccination with α-synuclein, long before α-synuclein-induced brain pathology, prevents striatal degeneration by inducing regulator...
Autores principales: | Christiansen, Josefine R., Olesen, Mads N., Otzen, Daniel E., Romero-Ramos, Marina, Sanchez-Guajardo, Vanesa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825077/ https://www.ncbi.nlm.nih.gov/pubmed/27055651 http://dx.doi.org/10.1186/s12974-016-0532-8 |
Ejemplares similares
-
CD4 T cells react to local increase of α-synuclein in a pathology-associated variant-dependent manner and modify brain microglia in absence of brain pathology
por: Olesen, Mads N., et al.
Publicado: (2018) -
Neuroimmunological processes in Parkinson's disease and their relation to
α-synuclein: microglia as the referee between neuronal processes and peripheral
immunity
por: Sanchez-Guajardo, Vanesa, et al.
Publicado: (2013) -
Microglia Acquire Distinct Activation Profiles Depending on the Degree of α-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease
por: Sanchez-Guajardo, Vanesa, et al.
Publicado: (2010) -
Microglia Response During Parkinson’s Disease: Alpha-Synuclein Intervention
por: Ferreira, Sara A., et al.
Publicado: (2018) -
The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
por: Deyell, Jacob S., et al.
Publicado: (2023)